IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

2,147
Loading...
Loading...
News
all
press releases
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
Ironwood shares jump 9.3% as second-quarter earnings and revenues top estimates. The company maintains its 2025 outlook.
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?
Zacks·3mo ago
News Placeholder
Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call
The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves.
Stocktwits·4mo ago
News Placeholder
Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
chainwire·4mo ago
News Placeholder
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday...
Business Wire·7mo ago
News Placeholder
Millrose Properties Set to Join S&P SmallCap 600
Millrose Properties Set to Join S&P SmallCap 600 Millrose Properties Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 5, 2025 NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Millrose Properties Inc...
PR Newswire·7mo ago
News Placeholder
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today...
Business Wire·7mo ago
News Placeholder
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies London...
Business Wire·10mo ago
News Placeholder
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2024 results and recent business performance. LINZESS continued to deliver robust...
Business Wire·10mo ago

Latest IRWD News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.